Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

Educating yourself about multiple sclerosis through credible sources and understanding your specific diagnosis type helps you make informed decisions about your care and treatment options.